Study on clinical diagnosis and treatment of upper gastrointestinal bleeding in gastroenterology
消化内科上消化道出血临床诊治的研究

摘要

目的：研究消化系统上消化道出血的临床治疗效果。方法：需要选取消化内科78例上消化道出血患者作为研究对象，采用分组式结果分析，研究人员按照数表法将该78例上消化道出血患者分为观察组（39例）与对照组（39例），抽取时间段介于2019年1月~2019年8月期间，均符合研究标准。对照组消化内科上消化道出血患者采用保守治疗方法，观察组消化内科上消化道出血患者在此基础上添加洛塞克与内镜止血治疗，研究期间需要护理人员做好记录工作，对比两组患者治疗有效率、头痛、头晕以及四肢乏力不良反应发生率。结果：观察组上消化道出血患者采用洛赛克联合内镜止血治疗，其治疗有效率为94.87%，对照组上消化道出血患者运用保守治疗方法，其治疗有效率为79.49%，观察组治疗效果优于对照组，组间差异显著（P＜0.05）。此外，观察组患者头痛、头晕以及四肢乏力不良反应发生率为5.13%，相较于对照组消化道出血患者不良反应发生率25.64%低，数据对比存在差异，具有实际统计意义（P＜0.05）。结论：对上消化道出血患者，在常规治疗的基础上添加洛塞克与内镜止血治疗，可以提升治疗效果，减少不良反应的发生，值得临床推广使用。

Abstract

Objective: To study the clinical treatment effect of upper gastrointestinal bleeding in digestive system.
Methods: 78 patients with upper gastrointestinal hemorrhage in the Department of Gastroenterology were selected as the research object, and the grouped results analysis was used. The researchers divided the 78 patients with upper gastrointestinal hemorrhage according to the number table method into an observation group (39 cases) and a control group ( 39 cases), the sampling time period is from January 2019 to August 2019, and all meet the research standards. The control group of patients with gastrointestinal upper gastrointestinal hemorrhage used conservative treatment methods, and the observation group of patients with gastrointestinal upper gastrointestinal hemorrhage added losec and endoscopic hemostasis treatment on this basis. During the study, nurses needed to make a record of the work. The patient's treatment efficiency, headache, dizziness and incidence of adverse reactions of limb weakness.
Results: The upper gastrointestinal hemorrhage patients in the observation group were treated with losec combined with endoscopic hemostasis, and the treatment effective rate was 94.87%. The conservative treatment method was used in the upper gastrointestinal hemorrhage patients in the control group, and the treatment effective rate was 79.49%. The effect is better than the control group, and the difference between the groups is significant (P <0.05). In addition, the incidence of adverse reactions of headache, dizziness and limb weakness in the observation group was 5.13%, which was lower than the incidence of 25.64% of patients with gastrointestinal hemorrhage in the control group. There was a difference in data comparison and it had practical statistical significance (P <0.05).
Conclusion  : For patients with upper gastrointestinal bleeding, adding Losec and endoscopic hemostatic treatment on the basis of conventional treatment can improve the treatment effect and reduce the occurrence of adverse reactions, which is worthy of clinical promotion.